Israeli MODI app receives FDA approval for type‑2 diabetes patients
The MODI app, developed in Israel to give personalized insulin dosage recommendations, has been approved by the U.S. Food and Drug Administration for use by patients with type‑2 diabetes who are on insulin.
What the 2 sources said
“האפליקציה MODI מספקת המלצות אישיות להתאמת מינוני אינסולין ישירות לנייד, ללא צורך באישור רופא • מדובר בפתרון הראשון שקיבל אישור FDA הן לסוכרתיים סוג 2 אשר מטופלים באינסולין”
Machine translation: The MODI app provides personal recommendations for adjusting insulin doses directly to a mobile phone, without needing a doctor's approval • This is the first solution to receive FDA approval for type‑2 diabetics treated with insulin
• האפליקציה נקראה על שמו של מודי אמיר ז"ל, שנהרג בכפר עזה ב-7 באוקטובר
Read at ישראל היום“Petah Tikva-based DreaMed Diabetes has just received FDA 510(k) clearance for MODI, a prescription medical application that automatically optimizes insulin dosing for adults with type 2 diabetes.”
Petah Tikva-based DreaMed Diabetes has just received FDA 510(k) clearance for MODI, a prescription medical application that automatically optimizes insulin dosing for adults with type 2 diabetes.
Read at The Jerusalem PostWhat the reports add
Written by AI from the outlets' own summaries, when someone asks. Each line names the outlets that reported it, and the words under it are theirs.